Yosuke Tanigawa

Mr. Yosuke Tanigawa

Stanford University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SSSaori Sakaue
Saori Sakaue
MKMasahiro Kanai
Masahiro Kanai
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
JKJuha Karjalainen
Juha Karjalainen
MKMitja Kurki
Mitja Kurki
YOYukinori Okada
Yukinori Okada

18 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NSNasa Sinnott-Armstrong
Nasa Sinnott-Armstrong
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
DADavid Amar
David Amar
NMNina Mars
Nina Mars
CBChristian Benner
Christian Benner
MRmanuel rivas
manuel rivas

30 August 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
EDEthan S. Dyer
Ethan S. Dyer
GBGill Bejerano
Gill Bejerano
We present WhichTF, a computational method to identify functionally important transcription factors (TFs) from chromatin accessibility measurements. To rank TFs, WhichTF applies an ontology-guided functional approach to compute novel enrichment by integrating accessibility measurements, high-confidence pre-computed conservation-aware TF binding sites, and putative gene-regulatory models. Comparison with prior sheer abundance-based methods reveals the unique ability of WhichTF to identify context-specific TFs with functional relevance, including NF-κB family members in lymphocytes and GATA factors in cardiac cells. To distinguish the transcriptional regulatory landscape in closely related samples, we apply differential analysis and demonstrate its utility in lymphocyte, mesoderm developmental, and disease cells. We find suggestive, under-characterized TFs, such as RUNX3 in mesoderm development and GLI1 in systemic lupus erythematosus. We also find TFs known for stress response, suggesting routine experimental caveats that warrant careful consideration. WhichTF yields biological insight into known and novel molecular mechanisms of TF-mediated transcriptional regulation in diverse contexts, including human and mouse cell types, cell fate trajectories, and disease-associated cells.

23 October 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JQJunyang Qian
Junyang Qian
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
WDWenfei Du
Wenfei Du
MAMatthew Aguirre
Matthew Aguirre
CCChris Chang
Chris Chang
THTrevor Hastie
Trevor Hastie
The UK Biobank is a very large, prospective population-based cohort study across the United Kingdom. It provides unprecedented opportunities for researchers to investigate the relationship between genotypic information and phenotypes of interest. Multiple regression methods, compared with genome-wide association studies (GWAS), have already been showed to greatly improve the prediction performance for a variety of phenotypes. In the high-dimensional settings, the lasso, since its first proposal in statistics, has been proved to be an effective method for simultaneous variable selection and estimation. However, the large-scale and ultrahigh dimension seen in the UK Biobank pose new challenges for applying the lasso method, as many existing algorithms and their implementations are not scalable to large applications. In this paper, we propose a computational framework called batch screening iterative lasso (BASIL) that can take advantage of any existing lasso solver and easily build a scalable solution for very large data, including those that are larger than the memory size. We introduce snpnet, an R package that implements the proposed algorithm on top of glmnet and optimizes for single nucleotide polymorphism (SNP) datasets. It currently supports ℓ1-penalized linear model, logistic regression, Cox model, and also extends to the elastic net with ℓ1/ℓ2 penalty. We demonstrate results on the UK Biobank dataset, where we achieve competitive predictive performance for all four phenotypes considered (height, body mass index, asthma, high cholesterol) using only a small fraction of the variants compared with other established polygenic risk score methods. With the advent and evolution of large-scale and comprehensive biobanks, there come up unprecedented opportunities for researchers to further uncover the complex landscape of human genetics. One major direction that attracts long-standing interest is the investigation of the relationships between genotypes and phenotypes. This includes but doesn’t limit to the identification of genotypes that are significantly associated with the phenotypes, and the prediction of phenotypic values based on the genotypic information. Genome-wide association studies (GWAS) is a very powerful and widely used framework for the former task, having produced a number of very impactful discoveries. However, when it comes to the latter, its performance is fairly limited by the univariate nature. To address this, multiple regression methods have been suggested to fill in the gap. That said, challenges emerge as the dimension and the size of datasets both become large nowadays. In this paper, we present a novel computational framework that enables us to solve efficiently the entire lasso or elastic-net solution path on large-scale and ultrahigh-dimensional data, and therefore make simultaneous variable selection and prediction. Our approach can build on any existing lasso solver for small or moderate-sized problems, scale it up to a big-data solution, and incorporate other extensions easily. We provide a package snpnet that extends the glmnet package in R and optimizes for large phenotype-genotype data. On the UK Biobank, we observe competitive prediction performance of the lasso and the elastic-net for all four phenotypes considered from the UK Biobank. That said, the scope of our approach goes beyond genetic studies. It can be applied to general sparse regression problems and build scalable solution for a variety of distribution families based on existing solvers.

24 March 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
JQJunyang Qian
Junyang Qian
GVGuhan Venkataraman
Guhan Venkataraman
JJJohanne Marie Justesen
Johanne Marie Justesen
RLRuilin Li
Ruilin Li
MRmanuel rivas
manuel rivas
We present a systematic assessment of polygenic risk score (PRS) prediction across more than 1,500 traits using genetic and phenotype data in the UK Biobank. We report 813 sparse PRS models with significant (p < 2.5 x 10−5) incremental predictive performance when compared against the covariate-only model that considers age, sex, types of genotyping arrays, and the principal component loadings of genotypes. We report a significant correlation between the number of genetic variants selected in the sparse PRS model and the incremental predictive performance (Spearman’s ⍴ = 0.61, p = 2.2 x 10−59for quantitative traits, ⍴ = 0.21, p = 9.6 x 10−4for binary traits). The sparse PRS model trained on European individuals showed limited transferability when evaluated on non-European individuals in the UK Biobank. We provide the PRS model weights on the Global Biobank Engine (https://biobankengine.stanford.edu/prs).

24 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CDChristopher DeBoever
Christopher DeBoever
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
MLMalene E. Lindholm
Malene E. Lindholm
GMGreg McInnes
Greg McInnes
ALAdam Lavertu
Adam Lavertu
MRmanuel rivas
manuel rivas
Protein-truncating variants can have profound effects on gene function and are critical for clinical genome interpretation and generating therapeutic hypotheses, but their relevance to medical phenotypes has not been systematically assessed. Here, we characterize the effect of 18,228 protein-truncating variants across 135 phenotypes from the UK Biobank and find 27 associations between medical phenotypes and protein-truncating variants in genes outside the major histocompatibility complex. We perform phenome-wide analyses and directly measure the effect in homozygous carriers, commonly referred to as “human knockouts,” across medical phenotypes for genes implicated as being protective against disease or associated with at least one phenotype in our study. We find several genes with strong pleiotropic or non-additive effects. Our results illustrate the importance of protein-truncating variants in a variety of diseases.